Ahrens Investment Partners’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | $195K | Sell |
2,555
-75
| -3% | -$5.72K | 0.1% | 149 |
|
|
2022
Q4 | $218K | Buy |
+2,630
| New | +$218K | 0.1% | 149 |
|
|
2022
Q3 | – | Sell |
-3,455
| Closed | -$257K | – | 922 |
|
|
2022
Q2 | $257K | Sell |
3,455
-3,068
| -47% | -$228K | 0.11% | 140 |
|
|
2022
Q1 | $586K | Buy |
6,523
+4,668
| +252% | +$419K | 0.18% | 90 |
|
|
2021
Q4 | $208K | Sell |
1,855
-1,965
| -51% | -$220K | 0.09% | 178 |
|
|
2021
Q3 | $480K | Sell |
3,820
-175
| -4% | -$22K | 0.23% | 108 |
|
|
2021
Q2 | $541K | Sell |
3,995
-615
| -13% | -$83.3K | 0.25% | 108 |
|
|
2021
Q1 | $625K | Buy |
4,610
+20
| +0.4% | +$2.71K | 0.32% | 92 |
|
|
2020
Q4 | $646K | Buy |
4,590
+1,100
| +32% | +$155K | 0.35% | 73 |
|
|
2020
Q3 | $389K | Sell |
3,490
-1,475
| -30% | -$164K | 0.26% | 87 |
|
|
2020
Q2 | $556K | Buy |
+4,965
| New | +$556K | 0.34% | 63 |
|
|
2019
Q2 | – | Sell |
-2,293
| Closed | -$208K | – | 174 |
|
|
2019
Q1 | $208K | Sell |
2,293
-600
| -21% | -$54.4K | 0.09% | 140 |
|
|
2018
Q4 | $208K | Sell |
2,893
-4,200
| -59% | -$302K | 0.1% | 136 |
|
|
2018
Q3 | $680K | Buy |
7,093
+3,158
| +80% | +$303K | 0.26% | 73 |
|
|
2018
Q2 | $375K | Sell |
3,935
-135
| -3% | -$12.9K | 0.16% | 93 |
|
|
2018
Q1 | $357K | Sell |
4,070
-965
| -19% | -$84.6K | 0.15% | 93 |
|
|
2017
Q4 | $427K | Buy |
5,035
+160
| +3% | +$13.6K | 0.17% | 84 |
|
|
2017
Q3 | $422K | Buy |
4,875
+1,505
| +45% | +$130K | 0.18% | 79 |
|
|
2017
Q2 | $260K | Hold |
3,370
| – | – | 0.11% | 108 |
|
|
2017
Q1 | $234K | Sell |
3,370
-5,252
| -61% | -$365K | 0.11% | 110 |
|
|
2016
Q4 | $510K | Buy |
+8,622
| New | +$510K | 0.27% | 63 |
|